This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11% — meaning more than one in 10 adults are on one form or another of the jab. This explosion in use of drugs like Ozempic, Wegovy and Mounjaro has happened over a very short time — about … Read more
Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The Massachusetts dad of four and beloved softball coach was just about the retire. Meanwhile, his sight was getting worse by the day. He desperately tried to nail down the cause quickly, but his vision loss deteriorated even … Read more
As GLP-1 medications continue reshaping the treatment of obesity and diabetes, researchers are also investigating whether the drugs could influence cancer risk and outcomes. The American Association for Cancer Research’s 2026 Cancer Progress Report, released earlier this month, noted that obesity is a major risk factor for many cancers. As glucagon-like peptide-1 medications – including … Read more
Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that the medications caused NAION (nonarteritic anterior ischemic optic neuropathy), according to The Wall Street Journal. NAION is a rare eye condition in which … Read more
It was the modern version of an indecent proposal. Shaylee Meurer, a 36-year-old plus-size influencer, once received a shocking offer from a major pharmacy brand: Take a popular GLP-1 drug for free, post about it on social media and reap a $7,000 reward. The big-time bid came at a vulnerable time for the content creator, … Read more
Two common GLP-1 weight loss drugs have been linked to a brain condition that can cause permanent brain damage and become deadly. More than one in 10 American adults are now on GLP-1s for weight loss. And while the jabs work to shed pounds and provide a host of other unexpected benefits, they can come … Read more
Stamie Giallourakis was on her deathbed in early 2021 when she made herself a promise. At the time, she was over 200 pounds and hospitalized with severe COVID-19. “I swore that if I survived — and I’m not being dramatic — I would try to once and for all be as healthy as I could … Read more
Talk about losing face. By now, people are well aware of “Ozempic face,” the phenomenon in which people on GLP-1 medications notice saggy skin, sunken eyes and gaunt cheeks. Now, “temporal wasting” is the latest side effect that prematurely ages weight loss drug users, and has doctors concerned. Along with “Ozempic face,” another side effect … Read more
July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37 percent higher than in … Read more
America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two years. Now, the shift is showing up on the scale, with national obesity rates edging lower after years … Read more
A woman went to the ER to deal with severe abdominal pain, nausea, and vomiting. She thought it might be due to stress. It turned out to be a goopy green mass that formed in her stomach — with a little help from her GLP-1. The 63-year-old was seen by doctors at Brigham and Women’s … Read more
There’s a nasty new job hazard to building employees in NYC’s most pampered zip codes — and it’s lurking in the trash. Residents at one luxe Upper East Side address received a sharp written warning after one staffer was shocked to discover they’d been jabbed by someone’s used needle while bagging building trash — and it wasn’t … Read more
The “fauxzempic” era is well underway. Many brands are marketing alternatives to GLP-1 weight-loss drugs, but certain foods may also boost the effects of the naturally occurring hormone responsible for reducing hunger and stabilizing blood sugar. A recent study found one diet that not only boosted GLP-1 but also increased longevity and reduced body fat. … Read more
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research. The study, set to be presented at ENDO 2026 (the Endocrine Society’s annual meeting) in Chicago this week, found that adults with obesity who lost weight with a GLP-1, such as Ozempic or Wegovy, “significantly reduced” their physical activity. In an Endocrine … Read more
Anti-fat jabs are throwing fashion a new curve. A staggering $5 billion in clothing inventory is at risk of going to waste thanks to fashionistas melting away their waists on GLP-1 drugs, per alarming new reports. As the A-list likes of singer Meghan Trainor and Sports Illustrated Swimsuit model Brooks Nader lead the charge in getting lean via Type 2 … Read more
There’s been a revolving door of viral social media posts recently promoting the idea that you’ll boost your chances of conceiving if you take GLP-1 weight-loss medications. Unfortunately, the promise of the “Ozempic baby boom” is more myth than reality. While there is some connection between GLP-1s (semaglutide, like Ozempic or Wegovy, or tirzepatide, like … Read more
You may yet be able to lean out without losing out, as a new drug could save GLP-1 users from the flat fate of “Ozempic butt.” A symptom of rapid weight loss, Ozempic butt is characterized by a sudden loss of volume and muscle in key areas, leaving users looking and feeling deflated. And Americans … Read more
Ear we go again. In yet another plastic surgery trend sparked by GLP-1 drugs like Ozempic, patients who have dropped the pounds are now longing to plump up their sagging lobes — which, according to plastic surgeons, is a fast and easy way to give ears back their “youthful” appearance. “It seems so random, but … Read more
Popular glucagon-like peptide-1 (GLP-1) weight-loss drugs may help slow the spread of some cancers, according to new research to be presented at a major medical conference. Research led by Cleveland Clinic found that the medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers. The findings will be presented at the 2026 ASCO … Read more
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more